Mar 04, 2024 / 02:50PM GMT
Stephen Michael Scala - TD Cowen, Research Division - MD & Senior Research Analyst
Well, good morning once again. We're delighted to have Bristol-Myers Squibb here at the Cowen 44th Annual Healthcare Conference. Representing the company is Roland Chen, who is Senior Vice President and Head of Immunology, Cardiology, or Cardiovascular, and Neuroscience Development. So thank you so much for making the effort to be with us.
Roland Chen -
Thanks, Steve.
Questions and Answers:
Stephen Michael Scala - TD Cowen, Research Division - MD & Senior Research AnalystYou're in charge of three critical areas to the outlook for Bristol-Myers Squibb. Just tell us in a very brief fashion, what is the central objective in each of these three areas, say, for the next 3 to 5 years?
Roland Chen -
Yes. So thanks for that question, Steve. It's a pleasure to be here. I think if I just think about the three areas, I mean let me start with cardiovascular. I think where we are focused is in
Trustpilot
